(i)
assisting the Community and Member States in the provision of information to health care professionals and the general public about medicinal products which have been evaluated within the Agency;
← (h) · All articles · (j) →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.